Term Name: elacestrant
Synonyms: (6R)-6-[2-(ethyl{4-[2-(ethylamino)ethyl]benzyl}amino)-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol, (R)-6-(2-(ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol, elacestrant, elacestrantum, ER-306323, Orserdu, RAD 1901, RAD-1901, RAD1901
Definition: A member of the class of tetralins that is 1,2,3,4-tetrahydronaphthalene which is substituted by hydroxy group at position 2 and by a 2-(ethyl{4-[2-(ethylamino)ethyl]benzyl}amino)-4-methoxyphenyl group at position 6R. It is a is an estrogen receptor degrader indicated for the treatment of postmenopausal women or adult men, with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.
Ontology: ChEBI [CHEBI:229213]  ( EBI )

Relationships
is a type of: monomethoxybenzene organic hydroxy compound secondary amino compound substituted aniline tertiary amino compound tetralins
has_role: anti-estrogen antineoplastic agent estrogen receptor antagonist